Literature DB >> 17881421

Addenbrooke's Cognitive Examination-Revised (ACE-R) in day-to-day clinical practice.

A J Larner1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17881421     DOI： 10.1093/ageing/afm112

Source DB:  PubMed          Journal:  Age Ageing        ISSN： 0002-0729            Impact factor:   10.668


× No keyword cloud information.
  6 in total

1.  Hypothalamic microstructure and function are related to body mass, but not mental or cognitive abilities across the adult lifespan.

Authors:  Melanie Spindler; Christiane M Thiel
Journal:  Geroscience       Date:  2022-07-27       Impact factor: 7.581

2.  Differential diagnosis of depression and Alzheimer's disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R).

Authors:  Augustinas Rotomskis; Ramunė Margevičiūtė; Arūnas Germanavičius; Gintaras Kaubrys; Valmantas Budrys; Albinas Bagdonas
Journal:  BMC Neurol       Date:  2015-04-17       Impact factor: 2.474

3.  A new diagnostic approach for the identification of patients with neurodegenerative cognitive complaints.

Authors:  Sabah Al-Hameed; Mohammed Benaissa; Heidi Christensen; Bahman Mirheidari; Daniel Blackburn; Markus Reuber
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

4.  Does cognitive impairment influence outcomes from cataract surgery? Results from a 1-year follow-up cohort study.

Authors:  Joanna Mary Jefferis; John-Paul Taylor; Michael Patrick Clarke
Journal:  Br J Ophthalmol       Date:  2014-10-06       Impact factor: 4.638

5.  Addenbrooke's Cognitive Examination-Revised is accurate for detecting dementia in Parkinson's disease patients with low educational level.

Authors:  Maria Sheila Guimarães Rocha; Elida Maria Bassetti; Maira Okada Oliveira; Roberta Gomes Borges Kuark; Nathercia Marinho Estevam; Sonia Maria Dozzi Brucki
Journal:  Dement Neuropsychol       Date:  2014 Jan-Mar

6.  Comparing Sensitivity and Specificity of Addenbrooke's Cognitive Examination-I, III and Mini-Addenbrooke's Cognitive Examination in Parkinson's Disease.

Authors:  Tivadar Lucza; Zsuzsanna Ascherman; Márton Kovács; Attila Makkos; Márk Harmat; Annamária Juhász; József Janszky; Sámuel Komoly; Norbert Kovács; Krisztina Dorn; Kázmér Karádi
Journal:  Behav Neurol       Date:  2018-10-02       Impact factor: 3.342
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.